As AD is a multifactorial disease, targeting AD related processes such as tau pathology, synaptic activity, neural epigenetic regulation of AD associated genes, and inflammatory responses may provide alternative treatment strategies (Karisetty et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.